NEW YORK, NY / ACCESSWIRE / December 31, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...

Vertex Pharmaceuticals (VRTX) ended the recent trading session at $468.09, demonstrating a +0.94% swing from the preceding day's closing price. This change outpaced the S&P 500's 0.38% gain on the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

An official government report has concluded that the Trump-era Department of Justice (DOJ) did not obtain the required authorizations before demanding customer call and message data from Apple and ...

Vertex Pharmaceuticals (VRTX) closed at $469.29 in the latest trading session, marking a -0.99% move from the prior day. The stock's change was less than the S&P 500's daily loss of 0.3%.

Vertex had developed the candidate as a treatment for rheumatoid arthritis, taking it as far as a midphase trial in the setting. When EIP merged with Diffusion Pharmaceuticals last year to create ...

Massad Boulos doesn’t have meaningful diplomatic experience, but he’s Tiffany Trump’s father-in-law; he campaigned for the Republican ticket this year; and so Donald Trump has chosen him to ...

Vertex Pharmaceuticals (NASDAQ:VRTX) presented positive long-term data for its gene therapy Casgevy and issued a business update on the product. The data showed 93% of treated patients ...

The MacBook Air is expected to switch to OLED in 2028 but will retain the notch design. Without any further details, the report says Apple is working on a foldable device of some sort with an OLED ...